Plasma Brain-Derived Neurotrophic Factor (BDNF) and Sphingosine-1-Phosphat (S1P) Are NOT the Main Mediators of Neuroprotection Induced by Resistance Training in Persons With Multiple Sclerosis - A Randomized Controlled Trial

Multiple Sclerosis and Related Disorders - United States
doi 10.1016/j.msard.2019.03.029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neuroprotection on Multiple Sclerosis: A BDNF Perspective

Journal of Neurology & Neurophysiology
2012English

Reduction of the Plasma Clearance of Brain-Derived Neurotrophic Factor(BDNF): Carboxyl-Directed Pegylation.

Drug Delivery System
Pharmaceutical Science
1998English

Decreased Cerebrovascular Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in the Diabetic Brain

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Brain Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Is Not Risk Factor for Bipolar Disorder

2019English

Bone-Derived Neurotrophic Factor (BDNF)

Science-Business eXchange
2010English

Detection of Brain-Derived Neurotrophic Factor (BDNF) With a Sandwich Assay on a Plasmonic Chip

Transactions of the Materials Research Society of Japan
2014English

Suboptimal Nutrition and Low Physical Activity Are Observed Together With Reduced Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration in Children With Severe Cerebral Palsy (CP)

Nutrients
NutritionFood ScienceDietetics
2019English

High-Mobility Group Box-1 Induces Decreased Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in the Diabetic Retina

Mediators of Inflammation
ImmunologyCell Biology
2013English

A Brain-Derived Neurotrophic Factor (BDNF) Haplotype Is Associated With Antidepressant Treatment Outcome in Mood Disorders

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy